Concurrent and Adjuvant Nimotuzumab Combined With Induction Chemotherapy Plus Chemoradiation in Nasopharyngeal Carcinoma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Concurrent and Adjuvant Nimotuzumab Combined With Induction Chemotherapy Plus Chemoradiation in Nasopharyngeal Carcinoma	Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, carcinoma, epithelial neoplasm, nasopharyngeal carcinoma, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, otorhinolaryngologic disease	Recruiting	Not applicable	2023-02-08		NCT05717790

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Fourth Affiliated Hospital of Guangxi Medical University	5
Guilin Medical University, China	9
LiuZhou People's Hospital	15
People's Hospital of Baise	1
People's Hospital of Guangxi Zhuang Autonomous Region	20
Second Affiliated Hospital of Guangzhou Medical University	70
The First People's Hospital of Qinzhou	1
Wuzhou Red Cross Hospital	20
Youjiang Medical College for Nationalities	4

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Affiliated Hospital of Youjiang Medical University for Nationalities	Baise City	China	1
Guilin Medical University, China	Guilin	China	1
Liuzhou People's Hospital	Liuzhou	China	1
Nanxishan Hospital of Guangxi Zhuang Autonomous Region	Guilin	China	2
People's Hospital of Baise	Baise City	China	1
Second Affiliated Hospital of Guangzhou Medical University	Nanjing	China	1
The First People's Hospital of Qinzhou	Qinzhou	China	2
The Fourth Affiliated Hospital of Guangxi Medical University	Liuzhou	China	2
Wuzhou Red Cross Hospital	Wuzhou	China	1